Insider · CIK 0001385113
Amos Bar-Shalev
Files at PLX (Protalix BioTherapeutics, Inc.). First filing Nov 19, 2025, latest Nov 19, 2025.
Amos Bar-Shalev files SEC Form 4 as director at PLX (Protalix BioTherapeutics, Inc.). Since Nov 19, 2025, Amos Bar-Shalev has reported 0 open-market buys worth $0 and 1 open-market sell worth $314, the latest filed on Nov 19, 2025.
A track record needs three past buys with six months of prices behind them; Amos Bar-Shalev has 0, so none is measured yet.
The newest scored trade: sold $314 of PLX on Nov 18, 2025, filed Nov 19, 2025, scored 35 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $314.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PLX: Protalix BioTherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | PLXsell Protalix BioTherapeutics, Inc. | $314 168 shares | -100% | - |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | PLX Protalix BioTherapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +17,000 | $0.00 | $0 | 17,000 | 39 d ago |
| Sep 3, 2026 | PLX Protalix BioTherapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +8,500 | $0.00 | $0 | 8,500 | 39 d ago |
| Nov 18, 2025 | PLX Protalix BioTherapeutics, Inc. | SOpen-market sale Common Stock | -168 | $1.87 | $314 | 0 | Nov 19, 2025 |
| Sep 3, 2025 | PLX Protalix BioTherapeutics, Inc. | AGrant or award Common Stockindirect: By Trust | +7,500 | - | - | 7,500 | Sep 4, 2025 |
| Sep 3, 2025 | PLX Protalix BioTherapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Sep 4, 2025 |
Questions about Amos Bar-Shalev
Answered from the filings on this page, as of the latest one.
Is Amos Bar-Shalev buying or selling?
In the last 12 months Amos Bar-Shalev reported 0 open-market buys worth $0 and 1 open-market sell worth $314 on SEC Form 4; the latest was sold $314 of PLX on Nov 18, 2025. Grants, option exercises and tax withholding are not counted.
How did Amos Bar-Shalev's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Amos Bar-Shalev has 0.
Where does Amos Bar-Shalev file Form 4?
Amos Bar-Shalev has filed Form 4 at PLX (Protalix BioTherapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.